Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas
Open Access
- 28 January 2018
- journal article
- review article
- Published by Wiley in Disease Markers
- Vol. 2018, 1-13
Abstract
Background. Hu-antigen R (HuR) is a posttranscriptional regulator of several target mRNAs, implicated in carcinogenesis. This review aims to present the current evidence regarding the biological role and potential clinical significance of HuR in head and neck carcinomas. Methods. The existing literature concerning HuR expression and function in head and neck carcinomas is critically presented and summarised. Results. HuR is expressed in the majority of the examined samples, showing higher cytoplasmic levels in malignant or premalignant cases. Moreover, HuR modulates several genes implicated in biological processes important for malignant transformation, growth, and invasiveness. HuR seems to be an adverse prognosticator in patients with OSCCs, whereas a correlation with a more aggressive phenotype is reported in several types of carcinomas. Conclusions. A consistent role of HuR in the carcinogenesis and progression of head and neck carcinomas is suggested; nevertheless, further studies are warranted to expand the present information.Keywords
This publication has 104 references indexed in Scilit:
- Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA StabilityMolecular Cell, 2011
- HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endotheliumBritish Journal of Cancer, 2011
- HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cellsBritish Journal of Cancer, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levelsProceedings of the National Academy of Sciences, 2008
- Diverse molecular functions of Hu proteinsCellular and Molecular Life Sciences, 2008
- Cdk1 is sufficient to drive the mammalian cell cycleNature, 2007
- Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancerOncogene, 2006
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- The IAP family: endogenous caspase inhibitors with multiple biological activitiesCell Research, 2000